Kaasim Mahmood joined Advent in 2005 with a background in clinical medicine, finance, and mergers and acquisitions.
Kaasim gained an MB BS from the Royal Free and University College Medical School in London, after which he joined Cutfield, Freeman and Co, a London based corporate finance boutique.
Since joining Advent, Kaasim has overseen the legal and financial aspects of almost all of Advent's investments, as well as being actively involved with several portfolio Companies including CN Creative and Speciality European Pharma.
Kaasim currently serves on the Board of F2G, NeRRe Therapeutics and PP Limited.
Links
Sign up to view 0 direct reports
Get started